藥學系

Medicine & Life Sciences

1. 3-(1-benzenesulfonyl-2,3-dihydro-1H-indol-5-yl)-N-hydroxyacrylamide 16%
2. Acetylation 14%
3. Acids 25%
4. Alzheimer Disease 15%
5. Anti-Inflammatory Agents 33%
6. Antineoplastic Agents 30%
7. Antioxidants 30%
8. Antrodia 14%
9. Apoptosis 51%
10. aristolochic acid I 20%
11. Autophagy 21%
12. benzenesulfonamide 14%
13. Biological Availability 20%
14. Breast Neoplasms 28%
15. Cell Death 18%
16. Cell Line 36%
17. Cell Movement 21%
18. Cell Proliferation 20%
19. Chinese Traditional Medicine 15%
20. Cohort Studies 32%
21. Colonic Neoplasms 19%
22. Colorectal Neoplasms 30%
23. Confidence Intervals 15%
24. Cyclooxygenase 2 28%
25. Databases 18%
26. Dinoprostone 17%
27. Diterpenes 16%
28. Down-Regulation 23%
29. Drug Delivery Systems 21%
30. Enzymes 15%
31. Ethanol 21%
32. Gene Expression 21%
33. Genes 27%
34. Glioblastoma 14%
35. Glycosides 15%
36. Growth 40%
37. Hepatocellular Carcinoma 14%
38. Heterografts 20%
39. High Pressure Liquid Chromatography 33%
40. hispidulin 14%
41. Histone Deacetylase 6 15%
42. Histone Deacetylase Inhibitors 77%
43. Histone Deacetylases 41%
44. Hydrolyzable Tannins 15%
45. Hydroxamic Acids 15%
46. In Vitro Techniques 51%
47. indoline 17%
48. Inflammation 20%
49. Inhibitory Concentration 50 53%
50. Interleukin-1 16%
51. isosteviol 24%
52. Kidney 17%
53. Lactic Acid 17%
54. Lignans 19%
55. Lipopolysaccharides 33%
56. Liquid Chromatography 15%
57. Liver 15%
58. Lung Neoplasms 19%
59. Macrophages 21%
60. Mass Spectrometry 17%
61. Matrix Metalloproteinases 14%
62. Messenger RNA 14%
63. Micelles 22%
64. Microtubules 19%
65. Molecular Dynamics Simulation 14%
66. Mucocutaneous Lymph Node Syndrome 30%
67. Nanoparticles 22%
68. Neoplasm Metastasis 15%
69. Neoplasms 66%
70. Nitric Oxide 22%
71. Nitric Oxide Synthase Type II 18%
72. Non-Small Cell Lung Carcinoma 25%
73. Osteoporosis 15%
74. osthol 19%
75. Pharmaceutical Preparations 41%
76. Pharmacists 20%
77. Pharmacokinetics 32%
78. Phosphorylation 21%
79. Population 40%
80. Prescriptions 15%
81. Prostatic Neoplasms 15%
82. Proteins 39%
83. Pyruvaldehyde 20%
84. Rabbits 19%
85. Reactive Oxygen Species 16%
86. Resveratrol 21%
87. Safety 15%
88. Serum 16%
89. Single Nucleotide Polymorphism 16%
90. Solubility 15%
91. Structure-Activity Relationship 14%
92. Tablets 14%
93. Taiwan 100%
94. Therapeutics 36%
95. Tubulin 24%
96. Tubulin Modulators 23%
97. Vorinostat 14%
98. Water 24%
99. Wounds and Injuries 14%
100. Xanthine Oxidase 20%

Chemical Compounds

1. 3-Hydroxybutyrate 10%
2. 50 Percent Growth Inhibition 13%
3. Acetylation 8%
4. Acid 18%
5. Alkannin 9%
6. Amount 12%
7. Antiacne 8%
8. Antiinflammatory 30%
9. Antineoplastic Agent 25%
10. Antioxidant Agent 29%
11. Antiproliferative 39%
12. Antitumor 26%
13. Apoptotic 19%
14. Application 18%
15. Aristolochic Acid 18%
16. Bioactivity 14%
17. Bioavailability 23%
18. Biological Marker 8%
19. Calcium(0) 9%
20. Cantharidin 14%
21. Cell Death 15%
22. Cell Viability 10%
23. Chitosan 9%
24. Colchicine 11%
25. Collagen 11%
26. Column Like Crystal 11%
27. Composite Material 13%
28. Disorder 13%
29. Dissolution 11%
30. Diterpenoid 8%
31. Dose 20%
32. Drug 60%
33. Enantiomer 9%
34. Ethanol 12%
35. Ethyl Acetate 8%
36. Flavonoid 14%
37. Food 8%
38. Free Radical 12%
39. Genetic Polymorphism 18%
40. Glucose 9%
41. Glycoside 13%
42. Granulation 9%
43. High-Pressure Liquid Chromatography 16%
44. Histone 53%
45. Hydrogel 9%
46. Hydrolysable Tannin 11%
47. Hydroxamic Acid 17%
48. Leaf Like Crystal 19%
49. Lignan 15%
50. Lipid 10%
51. Lipopolysaccharide 15%
52. Liquid 8%
53. Liquid Film 8%
54. Marker 13%
55. Metabolic 13%
56. Metabolite 22%
57. Methylglyoxal 14%
58. Micelle 12%
59. Microcrystallinity 9%
60. Modification 12%
61. Molecular Dynamics 8%
62. Molecule 8%
63. Nanocarrier 10%
64. Nanoparticle 14%
65. Nifedipine 8%
66. Nitric Oxide 23%
67. Osthole 9%
68. Oxidative Stress 14%
69. Peptide 10%
70. Percutaneous 18%
71. Pharmacokinetics 24%
72. Pharmacological Metabolism 10%
73. Plasma 24%
74. Poly(ethylene Glycol) 8%
75. Polymerization Reaction 12%
76. Polysaccharide 8%
77. Prostaglandin E1 8%
78. Prostaglandin E2 9%
79. Protective 11%
80. Protein 59%
81. Quercetin 11%
82. Reactive Oxygen Metabolite 13%
83. Resistance 13%
84. Resveratrol 12%
85. Retinal 9%
86. Safety 9%
87. Shikonin 11%
88. Sildenafil 8%
89. Simulation 10%
90. Solubility 10%
91. Structure-Activity Relationship 11%
92. Succinate 9%
93. Superoxide 9%
94. Tannin 9%
95. Time 9%
96. Vascular Targeting Agent 9%
97. Weight 9%
98. Western Blotting 10%
99. Wogonin 8%